A new mechanism shapes the naïve CD8+ T cell repertoire: the selection for full diversity by Goncalves, P et al.
This is a repository copy of A new mechanism shapes the naïve CD8+ T cell repertoire: 
the selection for full diversity.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/112240/
Version: Accepted Version
Article:
Goncalves, P, Ferrarini, M, Molina-Paris, C orcid.org/0000-0001-9828-6737 et al. (5 more 
authors) (2017) A new mechanism shapes the naïve CD8+ T cell repertoire: the selection 
for full diversity. Molecular Immunology, 85. pp. 66-80. ISSN 0161-5890 
https://doi.org/10.1016/j.molimm.2017.01.026
© 2017 Elsevier Ltd. This manuscript version is made available under the CC-BY-NC-ND 
4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright 
exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy 
solely for the purpose of non-commercial research or private study within the limits of fair dealing. The 
publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White 
Rose Research Online record for this item. Where records identify the publisher as the copyright holder, 
users can verify any specific terms of use on the publisher’s website. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
A new mechanism shapes the naïve CD8+ T cell repertoire:
the selection for full diversity   
Pedro Gonçalves *,†,§ , Marco Ferrarini ‡, Carmen Molina-Paris ‡, Grant Lythe ‡, Florence 
Vasseur *,† , Annik Lim* , Benedita Rocha *,† & Orly Azogui†
* Lymphocyte Population Biology Unit, CNRS URA 196, Institut Pasteur, Paris, France
† INSERM, U1151, CNRS, UMR8253, Faculté de Médecine Paris Descartes, Paris, France
‡ Department of Applied Mathematics, University of Leeds, Leeds LS29JT, UK
§ Present address: Innate Immunity Unit, INSERM, U668, Institut Pasteur, Paris, France
*Corresponding authors: P. Gonçalves, Institut Pasteur, 25 Rue du Dr. Roux, 75015 Paris,
France,  tel:  +33601080704,  e-mail:  pedro.goncalves@pasteur.fr;  and  B.  Rocha,  Institut
Pasteur, 25 Rue du Dr. Roux, 75015 Paris, France; tel: +33145688582; fax: +33145688921;
e-mail: benedita.rocha@inserm.fr
Abstract  
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
During thymic T cell differentiation, TCR repertoires are shaped by negative, positive
and agonist selection. In the thymus and in the periphery, repertoires are also shaped by strong
inter-clonal  and  intra-clonal  competition  to  survive  death  by  neglect.  Understanding  the
impact of these events on the T cell repertoire requires direct evaluation of TCR expression in
peripheral naïve T cells. Several studies have evaluated TCR diversity,  with contradictory
results.  Some of  these  studies  had intrinsic  technical  limitations  since  they  used material
obtained from T cell pools, preventing the direct evaluation of clone sizes. Indeed with these
approaches, identical TCRs may correspond to different cells expressing the same receptor, or
to several amplicons from the same T cell. We here overcame this limitation by evaluating
TCRB expression in individual naïve CD8+ T cells. Of the 2,269 Tcrb sequences we obtained
from 13 mice, 99% were unique. Mathematical analysis of this data showed that the average
number of naïve peripheral CD8+ T cells expressing the same TCRB is 1.1 cell. Since TCRA
co-expression studies could only increase repertoire  diversity,  these results  reveal  that  the
number  of  naïve  T cells  with  unique TCRs approaches  the  number  of  naïve cells.  Since
thymocytes undergo multiple rounds of divisions after TCRB rearrangement; and 3-5% of
thymocytes survive thymic selection events; the number of cells expressing the same TCRB
was  expected  to  be  much  higher.  Thus,  these  results  suggest  a  new  repertoire  selection
mechanism, which strongly selects for full TCRB diversity. 
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BM-  bone  marrow;  CDR3-  complementarity  determining  region;  “clonotypes”-  cells
expressing  identical  Tcrb chains;  HP-  homeostatic  proliferation;  LCMV-  Lymphocytic
Choriomeningitis  Virus;  LN-  lymph  nodes;  MHC-  Major  histocompatibility  complex;
MoAbs- monoclonal antibodies;  Ms.- manuscript; SP- spleen;  SPF- specific-pathogen-free
mice;  TCR- T cell receptor; 
1. Introduction
The  immune  system  is  known  to  have  Promethean  properties,  i.e.,  to  be  able  to
recognize all  types  of  natural  and artificial  antigens  introduced in the organism. It  is  yet
subject of debate how much this remarkable capability depends on the diversity or on the
cross-reactivity of peripheral T cell repertoires is still a subject of debate.
The antigen specificity of CD8+ T cells is determined by a dimer of TCRB and TCRA
chains,  which  binds  peptides  presented  by  the  major  histocompatibility  class  I  complex
(pMHC).  The  TCRB  and  TCRA  chains  have  three  regions  of  hypervariability,  the
complementarity determining regions (CDR). The CDR1 and CDR2 loops are encoded by the
germline V gene segment,  while the CDR3 loop is created by V(D)J recombination  (Von
Boehmer, 2004). The Tcrb rearrangements begin at the CD44lowCD25+CD4-CD8-TCR- (triple
negative 3-TN3) thymocyte differentiation stage by recombining one of each of 35 TRBV, 2
TRBD  and  12  TRBJ  genes  in  mice  (Lefranc,  2001).  A  semi-random  cleavage  of  the
recombination hairpins intermediates results in nibbling at the V-D-J junctions. These events,
and the further addition of N and P nucleotides, result in a major increase in CDR3 diversity.
TCR diversity studies are often focused on Tcrb CDR3 region because this region is the most
diverse portion of the TCR and functional/crystallographic analysis shows that the interaction
between the pMHC complex and the TCR is predominantly mediated via this region (Das et
al., 2015). The expression of an in-frame TCRB induces allelic exclusion, a burst of 6-8 cell
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divisions (Kreslavsky et al., 2012; Penit et al., 1995; Penit and Vasseur, 1997; Von Boehmer,
2004),  and  the  transition  to  the  ISP (immature  single  positive)  and  the  CD4+CD8+ (DP)
thymocyte differentiation stages. Thymocytes divide at the ISP and at least 3 times at the DP
stage (Kreslavsky et al., 2012). 
 A diversity of the peripheral T cell pools also depends on  Tcra rearrangements and
TCRB/TCRA pairing. Indeed, in DP cells Tcra chains are rearranged by recombining one of
each of 132  TRAV and 60  TRAJ fragments  genes in mice (Genolet et al.,  2012;  Lefranc,
2001). The same events occurring during TCRB V-D-J recombination also occur during Tcra
V-J rearrangements, inducing a major variability of the Tcra CDR3 region. Because the first
in-frame TCRA chain may not pair efficiently to the expressed TCRB chain, DP cells have the
ability  to  rearrange multiple  Tcra  chains  until  a  compatible  TCRAB dimer  is  formed.  In
theory, these events could generate a potential repertoire of more than 1015 different TCRs
(Von Boehmer, 2004).
It  is  estimated  that  in  the  mouse  thymus  around  5x107 TCRαβ+ thymocytes  are
generated each day (Shortman and Jackson, 1974; Von Boehmer, 2004). These cells undergo
negative, positive and agonist selection, or may die by neglect. Lastly, thymic egress is also
restricted  (Von Boehmer, 2004). Each of these selection events, as well as peripheral T cell
survival, is not solely dependent on the TCR-ligand interactions of each individual cell, but is
strongly influenced by competition between different T cells (Freitas and Rocha, 2000; Hao et
al.,  2006).  Because  it  cannot  be  deduced,  in  a  non-manipulated  mouse,  from  current
understanding of these multiple selecting events, the diversity of peripheral T cell repertoires,
this diversity must be measured directly. 
Several studies addressed this issue, with contradictory results. In the mouse, it was
claimed that 10% (Carey et al., 2016), 28% (Casrouge et al., 2000), 55% (Peaudecerf et al.,
2012) or 68% (Quigley et al.,  2010) of  Tcrb chains were unique. In humans, the reported
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number of unique TCRs ranges from 106 to 2x107 (Arstila et al., 1999, 2000; Qi et al., 2014;
Robins et  al.,  2009).  These differences could be partially due to differences in the T cell
populations studied, or/and by bias introduced by the methodology used to evaluate diversity
(PCR  amplification,  followed  by  spectrotyping  and  cloning  versus PCR  amplification
followed by next-generation sequence analysis). However, these approaches had common as
well as specific technical limitations.  None allows the evaluation of sequencing efficiency,
i.e., to identify the number of T cells that had their TCR actually amplified. None can exclude
bias introduced by primer competition or/and, in next-generation sequencing, by filters used
to eliminate potential PCR errors. In most studies these selection filters are not defined. In one
study  where  selected  filters  were  fully  described  reported  that  up  to  50%  of  the  TCR
sequences were eliminated (Nguyen et al.,  2011). Apart  from these biases,  the successive
preparation steps may reduce putative diversity  by preferentially  selecting more abundant
TCRs. Importantly, bulk studies are unable to identify the number and the size of different
clones.  After PCR amplification,  it  is  uncertain if  identical  TCR sequences correspond to
multiple cells sharing the same TCR or to multiple amplicons from the TCR of a single cell.
Lastly, in several cases it is not clear how representative the sample was, with respect to the
total number of T cells belonging to the same population. To overcome these limitations, TCR
expression must be determined in single cells. 
Several recent studies used single-cell approaches to determine TCR expression of to-
tal  naïve or naïve antigen-specific  cells  from non-immunized mice  (Cukalac et  al.,  2015;
Eltahla et al., 2016;  Quinn et al., 2016;  Stubbington et al., 2016). All these studies report a
higher diversity of Tcrb expression than that determined by bulk studies. In particular, Quinn
et al studied over 300 T cells (15-72 cells mouse) specific for a peptide of the influenza virus
using tetramers (Quinn et al., 2016). They observed that this naïve repertoire is almost com-
pletely diverse but did not determine overall TCRB repertoires.  Rigorous analysis of reper-
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toire diversity will require studies in which multiple mice are studied and the number of cells
sequenced in each mouse is representative of the total population from that mouse. Over more
than a decade, we have developed and validated the parameters required for quantifying the
expression of multiple mRNAs in single cells (Peixoto et al., 2004), including primer design
and concentrations required to prevent primer competition and the conditions of amplification
allowing the detection of as little as 2mRNA/cell, while preventing saturation. We now used
this experience to develop a single-cell approach allowing evaluating the Tcrb expression in
single-cells. Here, we describe the evaluation of the repertoire diversity in single CD8+ T cells
from specific-pathogen-free (SPF) adult mice. In contrast to bulk cell approaches, this single-
cell analysis allows evaluation of the sequencing efficiency since we directly determined the
number of cells where an in-frame Tcrb chain was sequenced.  Our approach prevents primer
competition, since a single primer pair is used for the PCR amplification of the Tcrb in each
individual cell. It allows direct evaluation of PCR errors, by sequencing simultaneously the
Tcrb of monoclonal TCR-Tg single-cells expressing known  Tcrb chains. Of the  2,269 Tcrb
chains we sequenced, 99% were unique. Mathematical analysis of representative samples in-
dicate that, solely based on Tcrb expression,  the average number of naïve CD8+ T cells ex-
pressing the same Tcrb is 1.1 cells. This average “clonotype” size is unexpected, taking into
account the number of divisions of TCRB expressing immature thymocytes. At the DN3 thy-
mocyte differentiation stage, the expression of an in-frame TCRB induces allelic exclusion, a
burst of 6-8 cell divisions (Kreslavsky et al., 2012; Penit et al., 1995; Penit and Vasseur, 1997;
Von  Boehmer,  2004),  and  the  transition  to  the  ISP (immature  single  positive)  and  the
CD4+CD8+ (DP) thymocyte differentiation stages. Thymocytes divide at the ISP and at least 3
times at the DP stage (Kreslavsky et al., 2012). Since immature thymocytes undergo at least
11 divisions after  Tcrb rearrangement  (Kreslavsky et al., 2012;  Penit et al., 1995;  Penit and
Vasseur, 1997; Von Boehmer, 2004), if all these divisions were productive up to 211 cells ex-
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pressing the same  Tcrb could be generated.   Even if  only 3-5% survive thymus selection
events (Huesmann et al., 1991), an average 62 to 102 cells should express the same  Tcrb.
Therefore, our results suggest that, superimposed on the known mechanisms of repertoire se-
lection  (negative,  positive,  agonist  and death  by  neglect),  a  remarkable  selection  for  full
TCRB diversity also occurs. 
2. Material and methods
2.1. Mice 
Specific-pathogen-free C57BL/6 (B6) mice expressing the CD45.2 allotype marker,
and CD45.1 Rag2-/- P14 (P14) mice expressing a transgenic TCR specific for LCMV epitope
GP33-41  (GP33) backcrossed onto the Rag2
-/- C57BL/6 (B6) background, were obtained from
our breeding colonies at the Centre de Distribution, Typage et Archivage (CDTA, Orleans,
France). All animal experiments were performed in accordance with National and European
Commission guidelines for the care and handling of laboratory animals and were approved by
the site ethical review committee. 
2.2. The evaluation of T cell numbers in each CD8+ T cell subpopulation. 
To  eliminate  blood-derived  T  cells,  SPF  B6  mice  (CD45.2+)  were  exsanguinated
before organ removal. From each mouse the spleen (SP), 2 femurs and 40 lymph nodes (LN)
were removed from each mouse. The identification of these LN was performed as described
previously (Anjuere et al., 1999;  Sung et al., 2013;  Van den Broeck et al., 2006).  Briefly,  a
control mouse was injected with china ink diluted in PBS.  The ink particles are phagocytized
by the LN macrophages, in such a way that each LN acquires a black color and becomes
easily visualized. This mouse was used as a reference to identify the LNs in experimental
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mice, which were not injected with china ink. The five small LN known to be located in the
thorax were not identified because they were obscured by blood loss into the mediastinum.
Using an inverted microscope, organs were totally cleaned of fat and other adjoining
tissues and distributed in 24-well plates in RPMI medium supplemented with 2% fetal calf
serum  and  HEPES  buffer,  together  with  0.5x106 Monoclonal  CD45.1+ P14  cells,  as  a
“reference population” that is crucial for carrying out accurate cell counts. The cells of the
reference population undergo the  same preparation  steps  as  CD8+ T cells,  allowing us  to
determine non-specific cell  loss during preparation steps  (average 50%). Cell  suspensions
were obtained by mechanical disruption with forceps followed by digestion with 0.5 mg/ml
collagenase  type  IV (Worthington  Biochemical  Corporation,  Lakewood,  NJ,  USA)  and  5
μg/ml deoxyribonuclease I (Sigma-Aldrich, St. Louis, MN, USA) for 30 min at 37°C in 5%
CO2 with agitation. We found these steps critical, since cell yields were much higher and the
cell suspensions cleaner when compared with those obtained by mechanical disruption alone.
Femoral bone marrow was extracted by inserting a syringe equipped with a 26-gauge needle
into one end of the bone and flushing with 3 to 4 mL RPMI containing 1% FCS.  The total
number of BM cells was obtained by multiplying the number of cells recovered from two
femurs by 7.9, as previously described (Slifka et al., 1995). We did not study blood cells, for
ethical restrictions, since mice must be kept alive during blood removal. 
For depletion of non-CD8+ T cells, cell suspensions were labeled with a cocktail of
biotin-conjugated monoclonal  antibodies (MoAbs) from BD Pharmingen (San Diego, CA,
USA) (anti-TER119, CD19, Mac-1, GR1, CD4, B220) and anti-biotin Dynabeads (Dynal AS,
Oslo, Norway) following the manufacturer's instructions. All these MoAbs were previously
titrated to determine the binding efficiency and the absence of non-specific binding/depletion. 
The combination  of  pMHC dextramers  and protein  kinase  inhibition  increases  the
range of TCR-pMHC interactions and dextramer sensitivity allowing the detection by pMHC
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multimers  of  cognate  T cells  with  low  TCR avidity  (Lissina  et  al.,  2009).  CD8+ T cell
enriched suspensions were  incubated with  50 nM dasatinib (30 min, 37 °C) (Lissina et al.,
2009), and labeled for 20 min at room temperature with APC or PE-labeled dextramers of
H-2Db pMHC  I  loaded  with  GP33  peptide  or  a  general  negative  control  dextramer  for
accessing  the  unspecific  and  background  staining  (Dextramers®,  Immudex,  Copenhagen,
Denmark, previously titrated on P14 Tg cells). This was followed by incubation at 4°C during
30 min with the following MoAbs obtained from BD Pharmingen (San Diego, CA, USA):
anti-CD45.1 (A20) PECy7, anti-CD45.2 (104) PerCP, anti-CD3ε (145-2C11) Brilliant Violet
510,  anti-CD8β  (H35-172)  Pacific  Blue,  anti-CD44  (1M781) APC-eFluor  780,  anti-Vb7
(TR310) PE and anti-Vb8 (F23.1) PerCP-Cy5.5.  Dead cells were excluded by Sytox Green
dead cell  stain (Thermo Fisher  Scientific,  MA USA).  For  cell  analysis  and counting,  the
labeled  populations  were  diluted  in  0.5  ml  of  FACS flow buffer  and  acquired  using  the
low-speed mode in a FACSCanto II flow cytometer (Becton Dickinson, Franklin Lakes, NJ,
USA). The use of low-speed mode was important, since it reduces both the cell loss during
acquisition and the background non-specific labeling. Although very time-consuming, in our
hands it is the best method to visualize rare cells clearly. Gates identifying dextramer labeled
cells were identified in P14 TCR-Tg cells, labeled with dextramers. The data analysis was
performed using FlowJo software (TreeStar, Ashland, OR). 
The methodology we use to count GP33+ cells is precise, but also laborious and time
consuming.  In  general,  we can  only  study one individual  mouse  per  day,  to  recover  the
number of LNs we studied, and to acquire data in diluted samples at the low speed mode.
Therefore it is not possible to count cells accurately, and to sort GP33+ populations in the
same experiment. For single-cell sorting we used the same method described above, but LN
cells were sorted from a smaller pool of LNs (brachial, inguinal, axillary and mesenteric),
with  the  gating  strategy shown in  Fig.1.  Single  cells  were  sorted  (FACS-Aria  II  system,
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Becton Dickinson, Franklin Lakes, NJ, USA) into 96-well PCR plates (purity > 99%) that
were immediately stored at -80 °C until required.
2.3. Single-cell cDNA synthesis, nested RT-PCR and sequencing
Analysis of Tcrb usage was carried out by a single-cell multiplex RT-PCR (Dash et al.,
2011) developed in our laboratory (Peixoto et al., 2004), followed by the direct sequencing of
the PCR products. For that purpose, we designed 21 TRBV external primers (Supplemental
Table 1), which cover the entire repertoire of functional TRBV genes. We validated that each
TRBV  primer  only  amplified  a  single  TRBV  chain,  i.e.,  all  primers  were  devoid  of
cross-reactivity,  and did not  compete with one another,  which allowed us  to  use them in
multiplex RT-PCR. The 3’ primers were specific of the TRBC region. Briefly, individual cells
were incubated at: (i) 42°C for 30 min to synthesize cDNA using specific external primers for
Tcrbv and  Tcrbc in 5 μl of reaction (ii) a first 35-cycle amplification step using 21  Tcrbv
external forward primers; 94°C for 5 min to melt; 5 cycles of 94°C for 30 sec, 68°C for 20 sec
and 72 °C for 1 min; 35 cycles of 94°C for 30 sec, 58°C for 20 sec and 72 °C for 1 min; 72°C
for 1 min to complete extension in 30 μl of reaction  (iii); and then a second, nested, PCR was
performed using 1 μl of the first-round product in 10 μl PCR reactions, with another set of
specific, validated, Tcrbv internal primers (Supplemental Table 1). The following parameters
were used: 94°C for 5 min to melt; 5 cycles of 94°C for 30 sec, 68°C for 20 sec and 72 °C for
1 min; 45 cycles of 94°C for 30 sec, 58°C for 20 sec and 72 °C for 1 min; 72°C for 1 min to
complete extension. Wells with successful amplifications were identified by migration of a
sample of the second PCR reaction on 2% agarose gel. When a band was present, 3 μl of the
second PCR product was treated with 1 μl of ExoSAP-IT (usb) in 7 μl reaction mixture at 37
°C for 40 minutes and subsequently at 80°C for 20 minutes. The cDNA-PCR products were
sequenced directly in 12 μl reaction mixture of 7 μl purified cDNA, 3 μM specific primers,
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and  0,4  μl  BigDye™  Terminator  v1.1  cycle  sequencing  kit  (Applied  Biosystems).  The
RT-PCR products were purified using PCR purification columns (QIAGEN) according to the
manufacturer’s instructions and sequenced by the Sanger reaction. Sequences were analyzed
according  to  the  ImMunoGeneTics/V-QUEry  and  STandardization  web-based  tool
(http://imgt.cines.fr). All TCRB nomenclature was according to Bosc and Lefranc (Bosc and
Lefranc, 2000). The CDR3 amino acid sequence region begins with the second conserved
cysteine encoded by the 3’ portion of the TRBV gene segment and ends with the conserved
phenylalanine  encoded  by  the  5’  portion  of  the  TRBJ  gene  segment.  The  number  of
nucleotides between these codons determines the length and the frame of the CDR3 region. It
must be noted that in all experiments, we tested both for possible contaminations and PCR
errors influencing our results. To detect possible contaminations, for each 8 tubes containing
one cell, we amplified an additional control empty tube, with both the first and the second
PCR reaction. To screen for putative PCR errors, 8-16 single cells from Mo TCR-Tg P14
mice were also sequenced in each individual experiment. In all experiments, we sequenced
the Tcrb of 184 individual P14 Monoclonal TCR-Tg cells. All these 184 single-cells expressed
the same tcrb, confirming the absence of PCR errors, as expected by the reduced size of the
amplicons.
 2.4.  Statistical analysis
Statistics  were  performed  using  Prism  5,  GraphPad  software  (San  Diego,  USA).
Statistical significance of the difference between two groups was evaluated by the Student’s
t-test. Differences were considered to be significant when p < 0.05.
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3. Results
3.1. Quantification of the naïve CD8+ T cell pools in SPF mice.
First we determined the precise number of CD8+ T cells in different lymphoid organs
of specific-pathogen-free 11-12 weeks old C57BL/6 (B6) mice, using a strategy described
previously (Sung et al., 2013). Briefly, a known number of naïve P14 CD8+CD45.1+  T cells
were added to the Petrie dish where CD45.2+ cell suspensions from each organ were going to
be prepared. This “reference population” undergoes the same preparation steps as the CD8+ T
cells from that organ, allowing evaluation of the proportion of cells lost during washes and
CD8+ purification steps.  We previously showed that  loss-rates were identical  for  different
CD8+ “reference” populations, independently of their initial number (Sung et al., 2013). An
extra procedure was carried out for bone marrow (BM) CD8+ T lymphocytes: since the BM is
highly vascularized leading to the contamination of BM cell suspensions by blood cells, these
suspensions were labeled with anti-CXCR4Abs that identify BM resident cells. CXCR4 and
its  ligand CXCL12 mediate  the homing of CD8+ T cells  in  the BM (Chaix et  al.,  2014).
CXCR4 signalling is essential to T cell retention in BM (Itkin et al., 2016; Petit et al., 2002)
and only CXCR4+ cells  were considered for BM counts. CD69 was also essential  for the
persistence of memory T cells in the BM environment (Shinoda et al., 2012) and most of these
CD8+ T cells express CD69 (results not shown). After CD8+ T cell enrichment, cells were
labeled with CD45.1, CD45.2, CD44, CD8β and CD3ε. The total number of CD45.2+ cells
was calculated based on the recovery of the CD45.1+ “reference population”, and CD8+ T cell
cells failing to express CD44 were considered to be naïve. The separation into CD44- and
CD44+ cells was based in the fluorescence minus one (FMO) of cells labeled with an isotype
control (Fig. 1). 
Different studies reported that the lymphoid organs of  an adult non-infected mouse
contain ~ 2-5x107 CD8+ T cells, but these numbers were not estimated directly (Casrouge et
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al., 2000; Jenkins et al., 2010; Pewe et al., 2004). Our direct counts of the CD8+ T cells in SPF
B6 mice are closest to  the lowest of the previous  extrapolations. We counted an average of
2x107  total CD8+ T cells  in the total peripheral lymphoid organs i.e, SP, total LN and BM
pools (Table 1). The total naïve CD44-  CD8+ T cell pool averaged 7x106 cells, the remaining
13x106 expressing CD44. 
3.2. Evaluation of Tcrb expression by individual CD8+ T cells.
For the validation of our single-cell method, we first studied a cohort of CD8+ T cells
isolated from the SP and 5 LN (Table 2, Mouse 4-M4).  The sequencing efficiency, i.e., the
number of the single-cells in which we sequenced an in-frame Tcrb chain, was 89.2%.  187 of
the  188  single-cells  expressed  unique  Tcrb chains  (Table  2,  Supplemental  Table  2).  To
determine if the single repeat we found in this cohort corresponded to two CD44+ cells,  we
studied  the  CD44-CD8+ populations  from  three  further  mice.  In  these  mice,  sequencing
efficiency ranged from 85-88% (Table 2, M5-M7). We detect all Tcrbv and Tcrbj genes (Fig.
2-A, B.  Supplemental Table 2). The relative distribution of cells expressing each Tcrbv was
consistent with  that  described  using  TCRVB  specific  Abs  (Kato  et  al.,  1994).   Those
expressing each  Tcrbj were as described previously (Candeias et al., 1991). As expected in
polyclonal repertoires, CDR3 lengths followed a Gaussian distribution, from 7-16 amino acids
(aa) (Fig. 2C). This data indicates the efficiency of our methodology: we amplified all Tcrbv
and Tcrbj at the expected frequencies, and our sequencing efficiency was high. To determine
if PCR errors could influence our results, in each experiment we also sequenced the  Tcrb
expressed by multiple single-cells from Monoclonal (Mo) P14 TCR-Tg mice.  All the 184
MoP14 Tg cells we studied in different experiments expressed the same Tg Tcrb, excluding
the possibility that PCR errors influenced our results (Supplemental Table 2). 
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 The  present  data  also  allowed  us  to  determine  other  characteristics  of  the  Tcrb
rearrangements. We found that 2.9% of individual cells expressed two in-frame Tcrb chains,
(Supplemental Table 2) confirming that Tcrb allelic exclusion is not absolute (Stubbington et
al., 2016). CD8+ T cells do not express the different TCRVB and the Tcrbj genes at the same
frequency, but it  is not known if this is due to non-random recombination or to selection
events (Kreslavsky et al., 2012; Von Boehmer, 2004). We compared Tcrbv usage in in-frame
and  out-of-frame  rearrangements  to  clarify  this  issue.  If  higher  TCRVB usage  is  due  to
preferential  rearrangements,  Tcrbv usage  by  in-frame  (selected)  and  out-of-frame
(non-selected) rearrangements should be similar. Alternatively, selection events could result in
different Tcrbv usage by out-of-frame and in-frame Tcrbv molecules. We found that two thirds
of  Tcrbv molecules  were  expressed  at  the  same  frequency  in  in-frame  and  out-of-frame
rearrangements (Fig. 3, Supplemental Table 2). However,  Tcrbv 13-2, 14, 26 and 29 were
more abundant in in-frame than out-of-frame rearrangements, indicating that CD8+  T cells
expressing these Tcrbv were enriched during ontogeny. On the other hand, the frequency of
Tcrbv 4, 15 and 24 was higher in out-of-frame rearrangements, indicating that cells expressing
these Tcrbv were counter-selected during ontogeny. In-frame and out-of-frame rearrangements
showed the same frequency of  Tcrbj usage (Supplemental Table 2).  We conclude that the
differences in the  TCRBV distribution found in the peripheral CD8+ T cell pool are mostly
due  to  preferential  Tcrbv rearrangements.  However,  the  expression  of  certain  TCRBV is
modified by selection events. Cells expressing these Tcrbv will be referred to as selected (S).
Concerning  the  composition  of  the  CDR3  region,  all  sequences  we  studied  had
nibbling  at  the  V-D-J  junctions  and 90% also had N additions,  indicating  that  they were
generated  after  birth  (Carlsson  and  Holmberg,  1990). These  results  suggest  that  T cells
generated during the fetal/perinatal period only represent a small fraction of the peripheral T
cell repertoire.  With respect to variability, cells expressing identical  Tcrb chains were very
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rare (Table 2,  Supplemental Table 2). In the four mice we studied, we did not find public
sequences shared between different mice (Supplemental Table 2). These results contrast with
previous reports using pooled cDNA or DNA from CD8+ populations in mice or man, which
reported a much lower diversity (Arstila et al., 2000; Qi et al., 2014; Robins et al., 2009).
Since the CD44-CD8+ samples that we analyzed represented an average of 3.8x10-3 %
of the total CD44-CD8+  naïve T cell pool, we wished to study a population with a greater
coverage. For that purpose, we first studied CD44-CD8+ T cells expressing either TCRBV13
or  TCRBV19,  the  number  of  sequences  analyzed  representing  respectively  2.1x10-2 and
5.7x10-2  % of total repertoire. However, 99.3% of VB19+CD44-CD8+ T cells still expressed
unique Tcrb sequences (Table 2, Supplemental Table 2). TCRVB13+ cells (which are enriched
during  selection  -S  cells-  Fig.  3)  had  a  slightly  reduced  diversity,  since  97%  of  these
sequences were unique (Supplemental Table 2). 
3.3. Evaluation of Tcrb expression by individual GP33-specific CD8+ T cells. 
To further select more representative samples, we studied CD8+ T cells recognizing the
immune-dominant GP33-43  peptide  from the  Lymphocytic  Choriomeningitis  Virus  (LCMV)
(GP33+  CD8+  T cells).  First  we determined the precise  number of  these cells  in  different
lymphoid organs of SPF B6 mice (Fig. 1).  We observed that the average total number (SP +
LN + BM)  of  CD44-GP33+ cells  was  2,734 ±  208,  CD44intGP33+ was  6,658  ±  677  and
CD44highGP33+ was 5,852 ± 401. Therefore, the majority of GP33+ CD8+ T cells did not have
the CD44- naïve phenotype. CD44highGP33+ cells were particularly abundant in the BM of
naïve mice (Fig. 1). We studied also a sub-dominant LCMV epitope (GP276) and another
unrelated antigen, ovalbumin (OVA). As expected the total number of GP276+ (9,530 ± 1,572)
were less abundant than GP33+  (15,244 ± 1,155), and OVA+ cells were also less abundant
(9,097 ± 1,432) (results not shown). 
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Next we studied the TCR characteristics of the GP33+-specific repertoire.  Previous
analysis  of TCR repertoires specific for the GP33 epitope showed a preferential  usage of
TRVB13 (Blattman et al., 2000;  Lin and Welsh, 1998). We also observed a dominant bias
toward  TRBV13,  up  to  39% of  CD44-GP33+ cells  expressing  TRBV13 (Figure  4A).  By
contrast, the expression frequency of TRBV29 was reduced from an average of 12% in total
naïve  cells  to  5% in  CD44-GP33+ cells.  Small  modifications  in  TRBV12-2  and  TRBV3
expression  frequency  were  also  found.  We found  that  the  distribution  of  TRBJ  genes  is
identical in both pools (results not shown). We stained CD8+ T cells with specific antibodies
for TRBV13 (anti-Vb8) and TRBV29 (anti-Vb7) in additional mice, confirming our results
derived from TCRB sequence analysis (Figure 4B, C). Of note, these Tcrb distributions were
common  to  GP33+ cells  from all  lymphoid  organs,  including  the  rare  CD44-GP33+ cells
present in the BM (results not shown).
Our study of  Tcrb expression by CD44-GP33+ cells produced samples that are much
more representative, corresponding to 7-21% of the total CD44-GP33+ pool in each mouse
(Table 3).  However,  as usual  in  the sorting of rare cells,  sequencing efficiency decreased
(from an average of 90% to 70%) but was still high. The study of antigen-specific cells could
reduce variability, since naïve T cells recognizing the same epitope could be more likely to
share  identical  Tcrb chains.  However,  the  sharing  of  such  identical Tcrb chains  between
antigen-specific cells was mostly been reported after pathogen infection and not in naïve T
cell repertoires (Kedzierska et al., 2004). Indeed, the variability of CD44-GP33+CD8+ T cells
we find was 98-100%, i.e.,  similar  to  that  found in the  total  naïve  T cell  pool  (Table  3,
Supplemental Table 3). 
Cells from different individuals may share identical TCRB chains. These public TCRs
were  previously  reported  in  mouse  (Kedzierska  et  al.,  2004).  Some public  TCRs can  be
generated from a near-germline V-D-J recombination, with no or minimal random template
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nibbling or nucleotide additions.  We did not find this type of public  Tcrb sequences in the
CD44-GP33+ repertoire. Others can be generated by “convergent recombination”,  individual
cells  expressing  different  Tcrb expressing  a  TCRB  protein  with  the  same  amino-acid
composition. A single CASSDWGRDTLYFG TCRB was shared between mouse 1 and 2, but
was absent in other mice. In these samples, from these 6 different mice we found a single
sequence equivalent to the P14 TCRB chain in mouse 1 (Supplemental Table 3), indicating
that this Tg-TCR is not particularly frequent in the naïve LCMV-specific pool. We conclude
that virtually all naïve GP33+ TCRB repertoires are private and diverse. 
The majority of the GP33+ CD8+ T cells in SPF young adult mice were not naïve but
rather expressed CD44. If CD8+ T cells from B6 mice only acquire CD44 expression after
antigen  stimulation  (Hao  et  al.,  2006),  and  these CD44high cells  are  known to  behave  as
memory cells (Freitas and Rocha, 2000; Haluszczak et al., 2009), then it must be concluded
that  the  majority  of  GP33high cells  in  non-infected  SPF  mice  are  antigen-experienced
cross-reactive cells (Fig. 1, Table 1). They may be generated by the homeostatic proliferation
that occurs immediately after birth, when the first naïve T cells leave the thymus to seed the
peripheral “empty” pool (Kieper and Jameson, 1999). However, 80% of CD44highGP33+ Tcrbs
had  N additions  (Table  4,  Supplemental  Table  3).  This  percentage  is  lower  than  that in
CD44-GP33+ T cells (90%) indicating that some degree of perinatal homeostatic proliferation
contributes to the CD44highGP33+  population. However, the majority (80%) is not generated
during the perinatal period. Immune responses to self or environmental antigens (microbiota
and food) are conjectured to generate these “mock” memory cells (Freitas and Rocha, 2000;
Jameson et al., 2015; Su and Davis, 2013). Surprisingly, the repertoire of CD44high cells was
also diverse (Table 4, Supplemental Table 3), indicating that selection pressures for diversity
are also occurring in the CD44high pool (Quinn et al., 2016).
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3.4. Mathematical and computational determination of Tcrb diversity.
We undertook a mathematical and computational study of the statistical properties of
the  sequences  of  samples  of  cells  taken  at  random,  under  different  hypotheses  for  the
distribution of “clonotype” sizes in the naïve CD8+ T cell repertoire, which are detailed in
bellow and in a previous manuscript (Lythe et al., 2016). 
We consider, from a general viewpoint, sampling from a repertoire containing a total
of S cells that are shared among N Tcrb “clonotypes”. That is, N is equal to the total number of
distinct  Tcrb sequences in the repertoire. We use the letter  i to denote a “clonotype” in the
repertoire  that  consists  of  ni  cells.  Thus,  we  have  i=1, 2,…, N  and
n1+n2+…+nN=S . The mean clonal size is denoted by  ń . It is equal to  S /N , the
mean  number  of  cells  per  “clonotype”.  Three  types  of  hypothesis  we  considered  are  as
follows:
i. That each individual “clonotype” has the same number of cells;
ii. That the “clonotype” sizes follow a simple distribution, for example the geometric dis-
tribution where (according to the data) there are more “clonotypes” with small size
than large clones;
iii. That there are two types of “clonotypes” in the repertoire, the majority represented by
one cell and a few made up of only few cells.  
iv. That there are two types of “clonotypes” in the repertoire, the majority represented by
one cell and a small minority of “clonotypes” that contain many cells.
Suppose that a sample of m cells is taken and the Tcrb of each of the cells is sequenced. We
define q to be the probability that one cell, randomly chosen from the total of S cells, is part of
the sample of size m:
q=
m
S
. Let  m0 be the number of distinct sequences in the sample,  and let  m1 be the
number  of  sequences  found  only  once  in  the  sample.  If  m2,m3 ,… is  the  number  of
sequences found twice, three times, ... then
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m0=m1+m2+m3+…       and       m=m1+2m2+3m3+… .  
Under hypothesis (i), the mean of the ratio m0/m  can be written
ḿ0
m
=1−
1
2
q (n−1 )+O ( (q (n−1 ) )2 ) .[1]           
3.4.1. Estimating the mean clonal size of the CD44-GP33+ subset
We concentrated on the GP33+ subset, since each of the 9 samples we collected from
different mice represent almost 10 percent of the total repertoire of GP33+CD8+ T cells. Here,
the value of  S is the total number of CD44-GP33+ cells, estimated to be 441 (BM) or 2293
(SP+LN). Thus, with sample size m between 94 and 271, the value of q is between 0.04 and
0.12. Hypothesis (i) is not consistent with the data: if n=1  then m is always equal to m0
; if n=2  or larger, the predicted values of the ratio 
m
m0
 are larger than those observed.
We evaluated if the data was compatible with other hypothesis.
Geometric distribution. We first consider the geometric distribution of values of numbers of
cells per clone, ni . The statement that ni has a geometric distribution with mean ń  is
that 
P (ni=k )=
1
ń (1−
1
ń )
k−1
,     k = 1, 2, ...
Note that ń ≥1 . The fraction of clones that consists of only one cell is 
P (ni=1 )=
1
ń
.
If the distribution of values of ni is geometric, then the distribution of the number of copies
of each  Tcrb sequence found in a sample of  m cells is also geometric, with mean equal to
19
1
2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
1+(ń−1)q .  That is, the mean of the ratio m/ m0  is 1+(ń−1)q . Because the values
of S and m are known, we obtain one estimate of ń  from each measured value of m0 :
ń=1+S ( 1m0−
1
m ) .[2]
We use  [ii] to estimate  ń  in the CD44-GP33+ repertoire .  There are six independent
measurements:
• Mouse 5 (SP and LN, S=2293): 271 sequences, 268 unique, so estimate ń=1.09.
• Mouse 6 (SP and LN, S=2293): 188 sequences, 186 unique, so estimate ń=1.13.
• Mouse 7 (SP and LN, S=2293): 128 sequences, 127 unique, so estimate ń=1.14 .
• Mouse 10 (SP and LN, S=2293): 244 sequences, 240 unique, so estimate ń=1.16.
• Mouse 11 (SP and LN, S=2293): 165 sequences, 165 unique, so estimate ń=1.00.
• Mouse 12 (BM, S=441): 94 sequences, 93 unique, so estimate ń=1.05 .
The mean of the estimated values of ń  is 1.10, with standard deviation 0.06.
Poisson. As a check that our estimate of a mean clonal size not much larger than one is not
due to a particularity of the geometric distribution, we now consider the hypothesis that the
number of cells per clone, in the repertoire, has a Poisson distribution. The statement that
ni has a positive Poisson distribution with mean ń  is that 
P (ni=k )=
1
e
λ−1
λ
k
k !
k=1,2,…,where ń=
λ e
λ
e
λ−1
.[3]
In this case, the distribution of the number of copies y i  of each Tcrb sequence found in a
sample of m cells is also positive Poisson, with 
P ( yi=k )=
1
e
λq−1
(λq)k
k !
k=1,2,…
The  mean  value  of  
m
m0
is  
λq e
λq
e
λq−1
 which,  because  λq≪1,  we  can  expand  as
1+
1
2
λq+
1
4
( λq)2+…. Retaining up to first order in λq, gives
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                                   λ=2S( 1m0−
1
m ) .[4 ]
For each mouse, we estimate λ using [6], then calculate ń  using [4]:
• Mouse 5 (SP and LN, S=2293): 271 sequences, 268 unique, so estimate ń=1.10.
• Mouse 6 (SP and LN, S=2293): 188 sequences, 186 unique, so estimate ń=1.14 .
• Mouse 7 (SP and LN, S=2293): 128 sequences, 127 unique, so estimate ń=1.15.
• Mouse 10 (SP and LN, S=2293): 244 sequences, 240 unique, so estimate ń=1.17.
• Mouse 11 (SP and LN, S=2293): 165 sequences, 165 unique, so estimate ń=1.00.
• Mouse 12 (BM, S=441): 94 sequences, 93 unique, so estimate ń=1.05.
The mean of the estimated values of ń  is 1.10, with standard deviation 0.06. 
Thus, these two different mathematical approaches give similar estimates of 1.1 as the mean
number of cells per “clonotype”.
3.4.2. Estimating the mean clonal size of the CD44highGP33+ subset
Table IV summarizes data from single-cell Tcrb sequencing of CD44highGP33+ cells:
• Mouse 14 (BM, S=2178): 99 sequences, 99 unique, so estimate ń<1.10 .
• Mouse 15 (BM, S=2178): 71 sequences, 71 unique, so estimate ń<1.20 .
• Mouse 16 (BM, S=2178): 69 sequences, 69 unique, so estimate ń<1.20 .
Because no repeats were found, the estimates of ń  are upper limits.
 
3.4.3. Estimating the mean clonal size of the PB1-F262 subset
Quinn et al. studied the number and phenotype of influenza A virus-specific CD8+  T
cells, selected using tetramers, in B6 mice (Quinn et al., 2016).   They performed single-cell
Tcra and Tcrb sequencing of one such population, specific for DbPB1-F262 influenza A virus
peptide.  Consistent  with  our  results,  they  observed  that  the  naïve  repertoire  was  almost
completely diverse, with only a small number of repeated Tcrb sequences. Here, we take their
published Tcrb chain sequencing data (Dataset S1) and obtain estimates of the mean number
of cells per clonotype, using [2] with S=150. 
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• Mouse 1: 30 sequences, 28 unique, estimate ń=1.36.
• Mouse 2: 28 sequences, 28 unique, estimate ń=1.00.
• Mouse 3: 11 sequences, 11 unique, estimate ń=1.00.
• Mouse 4: 16 sequences, 16 unique, estimate ń=1.00.
• Mouse 5: 26 sequences, 24 unique, estimate ń=1.48.
• Mouse 6: 20 sequences, 20 unique, estimate ń=1.00.
• Mouse 7: 74 sequences, 72 unique, estimate ń=1.06.
• Mouse 8: 37 sequences, 37 unique, estimate ń=1.00.
• Mouse 9: 47 sequences, 44 unique, estimate ń=1.22.
• Mouse 10: 38 sequences, 37 unique, estimate ń=1.11.
3.4.4. Clonotypes with two cells
In the GP33+ subset, we could ascribe the occurrence of repeated Tcrb sequences in our
data to the existence of clonotypes with two cells in the repertoire. Can the same explanation
hold for the full naïve repertoire?
There are  N clonotypes  in the repertoire  of  S cells.  We denote the number of clonotypes
consisting of one, two, three … cells by N1, N2, N3, …. That is,
N = N1 + N2 + N3 + …
and
S = N1+ 2N2 + 3N3 + …
The probability that both cells of a clonotype that has two cells in the repertoire are found in a
sample of m cells is
r2 = m(m-1)/S(S-1).
Since there are N2 such clonotypes, the mean number of pairs of cells in the sample that are
the only two cells of their type in the repertoire is
R2 = N2r2 ~ N2 m
2/S2.
In order for there to be, on average, one such repeated Tcrb per sample of m cells, we need N2
~ (S/m)2.
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Antigen-specific repertoire:  m=100 and S=2300. We need N2=232 = 529, which is possible.
For example, the data from GP33+ subset could be attributed to 1242 cells with unique Tcrb
and 529 doublets.
3.4.5. The naïve CD8+ repertoire
Tables  II,  III  and  IV  summarize  single-cell  sequence  data  from  the  naïve  CD8+
repertoire (M4) and a variety of repertoire subsets (M5-M16). The values of  S range from
0.27 ×  10
6  (M9) to 17×10
6  (M4), with values of m between 83 and 188 and, hence,
values of q are between 0.005 and 0.00001. The mean clonal size in the naïve CD8+ repertoire
is therefore the same as that of the GP33+ subset (not shown). However, hypothesis (iii) is not
compatible  with the  overall  naïve  CD8+ repertoire:  m=100 and  S=106.  We need N2=1010,
which is impossible. Finding repeated Tcrb sequences in average once per sample of 100 cells
from a repertoire of 1 million cells cannot be due to “clonotypes” in the naïve repertoire with
two cells.
In the case of the naïve CD8+ repertoire, and the subsets restricted to TRBV13 and
TRBV19 expression,  the  detection  of  one  or  two repeated  sequences  per  sample  is  only
consistent with the hypothesis (iv) that rare large “clonotytpes” exist in the naïve repertoire. It
must be noted that the majority of the repeated sequences found in CD8+ T cell repertoires
express  the  selected  Tcrbv,  i.e.,  those  Tcrbv that  are  more  abundant  in  in-frame  than
out-of-frame rearrangements.  
We  conclude  that  by  using  different  mathematical  approaches,  and  by  studying
different samples collected from up to 13 mice as well as the data from (Quinn et al., 2016)
collected from 10 mice, the average clonotype size of peripheral CD8+ T lymphocytes is 1.1
cell.  These results show that taking into consideration only  Tcrbv diversity, the number of
unique TCRB chains approaches the number of naïve T cells.
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4. Discussion
When we initiated this work, we aimed to study TCR diversity by co-amplifying both
the Tcrb and the Tcra chains expressed by each individual cell. The present results show that
such complex study is not justified, since it would not modify considerably the estimations of
the total diversity of the naïve CD8+ T cell pool, based on the current single-cell  Tcrb chain
expression study. Of the 2,269 in-frame Tcrb chains we sequenced in individual cells, 2,248
(99%) were unique. This extensive diversity was not a property of a single sample. It was
shared by all samples we studied from 13 individual mice; it was present in samples from
total CD8+ T cells,  from CD8+ T cells  expressing a single TCRVB, and even from naïve
CD44-GP33+  and CD44+GP33+  CD8+ T lymphocytes.  Overall,  the mathematical analysis of
our results show that the average Tcrb distribution in the naïve CD8+ T cell pool is 1.1 cells,
i.e.,  the  number  of  different  Tcrb expressed  by  naïve  CD8+ T cells  approaches  the  total
number of the naïve CD8+ T cells. The addition of Tcra expression studies could only increase
diversity (Cukalac et al., 2015).  Therefore, the study of Tcra co-expression would not modify
the general conclusion of this study: the number of different TCRs expressed by naïve CD8+ T
cells approaches the total number of the naïve CD8+ T cells. 
Our conclusions differ from some of the previous reports  in several aspects. Firstly,
our study contradicts previous studies indicating less repertoire diversity in both mouse and
man (Arstila et al., 1999,  2000;  Casrouge et al., 2000;  Qi et al., 2014;  Robins et al., 2009).
However,  these studies  had limitations that  can only be overcome by studying individual
cells. All of them amplified samples of T cells using pools of multiple primers. Therefore,
they cannot determine sequencing efficiency, i.e., the number of T cells that had their TCRs
actually  identified.  These  amplification  conditions  (when  multiple  primers  are  used
simultaneously for amplification) favor primer competition, which increases with the number
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of primers present during amplification (Peixoto et al., 2004), and is facilitated by the many
similarities  among the  Tcrb genes.  In  conditions  of  primer competition,  larger  clones  are
preferentially amplified. The cloning of bands with the same CDR3 size after spectrotyping
will further select for more abundant amplicons. Exhaustive next-generation sequencing was
reported to be insufficient to capture the full  repertoire of a subject (Warren et al.,  2011;
Zarnitsyna et al.,  2013), the PCR amplification overestimating the repeated observation of
TCR  clonotypes  in  the  sample, leading  to  false  saturation  (Robins  et  al.,  2009).
Next-generation sequencing is also associated with multiple PCR errors (Nguyen et al., 2011).
The criterion used to select “true” sequences varies and is rarely described; in studies clearly
defining this criterion, up to 50% of sequences were rejected (Nguyen et al., 2011). Rare TCR
sequences might be mistaken for error-containing sequences and ignored, while larger clones,
generating more abundant amplicons, have an increased probability that at least some of these
amplicons are accepted as “true sequences”, once again artificially reducing the estimates of
repertoire  diversity.  Importantly, bulk studies  cannot  estimate  clone  sizes,  and  therefore
evaluate repertoire diversity. They cannot determine whether identical amplicons derive from
the  same  cell  or  correspond  to  multiple  cells  expressing  the  same  TCR.  Our  approach
overcomes these limitations. We counted precisely the number of cells where the Tcrb chain
was sequenced. We had no primer competition since, for each individual cell, a single pair of
primers was used for  Tcrb chain amplification.  In this single-cell analysis, the frequency of
Tcrbv gene expression  was  consistent  with that  determined  by  cell  surface  staining  with
specific TCRB antibodies. Moreover, we are able to avoid the possibility that PCR errors bias
our  diversity  estimates.  In  each  experiment,  we  amplified  the  Tcrb from  individual
monoclonal  P14 CD8+ T cells  expressing a  known transgenic  TCRB.  All  these  cells  had
identical tcrb sequences. 
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As  a  preliminary  step,  we  established  why  different  TCRVBs  were  expressed  at
different frequencies in the peripheral pools. By comparing the frequency of Tcrbv families in
the  out-of-frame  (non  selected)  and  in-frame  (selected)  naïve  cells,  we  showed  that  the
majority of Tcrbv chains were expressed at similar frequencies in in-frame and out-of-frame
rearrangements, indicating that their expression frequency was determined by the frequency
of the respective  Tcrbv  rearrangements.  However,  some  Tcrbv genes (e.g.  Tcrbv 29) were
more  abundant  in  in-frame  than  out-of-frame  rearrangements,  while others  were  less
abundant.  These selections could occur already at the DN3 stage, by a different capacity of
each TCRVB to associate with the pre-Tα chain. Indeed, the enrichment in Tcrbv 29 we here
confirm was described to occur at the DN3-DN4-DP transition (Wei et al., 2006). However,
the selection process may differ for different TCRVB chains,  occurring  at any stage after
TCRA expression. It is possible that different TCRVB have different capacities to associate
with TCRA chains, or form TCRA/B heterodimers with different avidity to bind to MHC. All
these events could modify the efficiency of the thymus positive selection process, or/and of
the peripheral T cell survival. To our knowledge, these aspects are yet to be studied with the
necessary  detail.  In  the  sole  study where  the  TCRB and TCRA chain  co-expression was
studied in individual cells,  no preferential  TCRB/TCRA association was detected,  but  the
number of individual cells evaluated was relatively small (Dash et al., 2011).  
Considering the reliability of our approach, determination of overall  TCR diversity
requires  that  multiple  individual  mice  be  evaluated  and that  the  samples  studied  in  each
mouse are representative of the total TCR pool. For a rigorous study of the repertoire of the
total naïve T cell pool, a representative sample (an average of 106cells/per mouse) should have
been studied. Since for each cell a specific amplification for each  Tcrbv is performed, such
study would require  7x106 PCR/sequences/cell (7 different PCRs per mouse  for sequencing
106 cells), a total of 2.1x107 individual sequences for three mice. Therefore, although we also
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performed the mathematical analysis  of diversity  in the total  naïve CD8+ T cell  pool,  we
focused our mathematical analysis of repertoire diversity on naïve CD44-GP33+ cells, where
we can study representative samples  in each mouse,  corresponding to  7-20% of the total
CD44-GP33+ pool.
It must be considered if the pool of GP33+  cells we studied,  which were much more
abundant  than  previously  described,  could  be  contaminated  with  non-specific  naïve  cells
which could artificially reduce diversity. Indeed, the number of GP33+CD8+ in naïve mice
varied from 300 cells/mouse  (Obar et al.,  2008) to 1,000-1,200/spleen (Pewe et al.,  2004;
Seedhom  et  al.,  2009).  The  differences  in  our  methodology  approach  go  some  distance
towards explaining these different results. Firstly, we did not study the same organs: of the 46
to 49 LNs described in the mouse we studied 40-42 while previous studies only studied 5
LNs, so that 41 to 44 LN were simply missing from their counts (Obar et al., 2008). One
could envisage that all the larger LNs were studied, but that was not the case: para-aortic and
some of the neck LNs are much larger than the axilliary and inguinal LN that they studied. We
found that by studying this reduced LN pool, 50-60% of the LN CD8+ T cells are lost (Sung,
C. & Rocha, B. unpublished observations). Lastly, we have also evaluated the antigen-specific
cells residing in the BM. The total number of CXCR3+CD8+ T resident BM cells was around
3x106, i.e., the absence of BM counts also reduced the total CD8+ cell yields by 15%. Since
GP33+ cells are particularly abundant in the BM, the absence of BM counts reduces the GP33+
pool by 35%. 
We also did not use the same methods to isolate Ag-specific cells. In previous studies (Obar et
al., 2008) organs were dissociated by mechanical disruption alone, while we removed all fat
under  an  inverted  microscope  with  10-30  fold  amplification  and  further  digested  cell
suspensions with collagenase (that increases cell yields) and DNAase (that removes debris
and dead cells preventing the formation of clumps, thus decreasing cell loss during washing).
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In  our  experience  (Rocha,  B.  unpublished),  cell  viability  is  much  increased  by  fully  fat
removal and the cell yields/organ increased by these further digestion steps. Positive selection
of tetramers+ cells was reported to lead to the loss of 45-60% of antigen-specific cells (Lee
and  Lufkin,  2012;  Moon  et  al.,  2009),  most  of  low-affinity  antigen-specific  cells  being
probably lost during this step (Dolton et al., 2015; Hadrup et al., 2009). By contrast, we did
not perform positive selection of antigen-specific cells, but rather depleted cell suspensions of
non-CD8+ T cells and calculated loss rates, by introducing to the cell suspension a precise
known number  of  a  “reference  population”  which  undergoes  the  same preparation  steps.
Evaluation of loss rates was not previously performed (Haluszczak et al., 2009; Nunes-Alves
et al., 2015; Obar et al., 2008; Seedhom et al., 2009). 
As described in our methods section, we used dextramers rather than tetramers to identify
antigen-specific  cells,  and  dasatinib  pre-treatment  which  blocks  antigen  induced  TCR
down-regulation  and enhances  peptide-MHC multimer fluorescence  (Lissina  et  al.,  2009).
New generation peptide-MHC multimers were shown to detect more antigen-specific T cells
compared with the equivalent tetramers and the positive selection of antigen-specific cells can
be avoided  (Huang et al., 2016). By contrast,  the use of pMHC  tetramers was reported to
underestimate  cells  with  lower  affinity  TCRs  while  pMHC  dextramers  are  able  detect
antigen-specific cells with lower TCR avidity (Dolton et al., 2014; Massilamany et al., 2011)
increasing the total number of antigen specific CD8+  T cells detected  (Hataye et al., 2006;
Huang et al., 2016;  Obar et al., 2008).  Moreover, it was claimed that  this strategy increases
the detection of antigen-specific cells without  altering CD8+  T cell phenotype and inducing
unspecific  staining (Dolton et al.,  2014;  Lissina et  al.,  2009). Dextramers are specific for
CD8+ T cells, do not bind to CD4 cells and yield minimal background staining comparable to
tetramers over a broad range of concentrations (Massilamany et al. 2011; Dolton et al. 2014;
Huang,  et  al.  2016).  Indeed,  low affinity  antigen-specific  cells  that  “escape”  the  positive
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selection  using  tetramer+ cell  enrichment  can  be  further  identified  by  the  use  of  these
multimers (Huang et al., 2016). We showed that antigen-specific cells identified with MHC I
multimers  differentiate  into  cytotoxic  cells  after  stimulation  with  the  respective  peptides
(Munitic et al.,  2009;  Sung et al., 2013), while other studies demonstrate that low affinity
multimer-binding  identifies  antigen-specific  cells  since  they  showed  effector  cytokine
responses comparable to those of high-affinity tetramer+ cells (Huang et al., 2016).  Lower
affinity  CD8+ T cells  are  also  active  participants  in  the  immune  response  (Martinez  and
Evavold,  2015;  Ozga et  al.,  2016),  even extremely  low-affinity  TCR stimulation  induces
normal CD8+ T cells activation and memory generation (Oberle et al., 2016;  Tungatt et al.,
2015).   It  must  be  noted,  however,  that  the  methodology we used may have limitations.
Dextramer+ CD8+ T  cells  show  a  continuum  of  labeling  intensities,  rather  than  defined
clear-cut populations, well separated from negative cells. The barrier separating GP33+ from
GP33- CD8+ T cells was established by using CD8+ T cells non-labeled with dextramers and
MoP14 TCR-Tg cells labeled with dextramers. Using these barriers, many cells show low
dextramer labeling. We conclude that our approach has significantly refined the number of
steps for positive identification of naïve antigen-specific CD8+ T cells. However, there is still
the risk that inclusion of lower affinity TCRs and flow cytometric background events has
included  cells  that  are  not  functionally  recruited  to  the  immune  response  after  LCMV
infection.   
Our mathematical analysis focused on what can be deduced, using our samples about the
number  of  cells  expressing  unique  Tcrb  or  Tcrb “clonotytpe”  subsets  and  distribution  of
number  of  cells  per  “clonotype”.  Computational  experiments,  in  which  a  repertoire  is
constructed in silico, based on different hypothesized distribution of clonotype sizes, and then
sampled from, are used to validate mathematical conclusions.  These mathematical analyses
showed that Tcrb repertoires were compatible with a Geometric and Poisson distribution, the
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probability of finding “clonotypes” with small size being much higher than that of finding
large clones.  However it was possible that the rare repeated sequences we found reflected the
presence of two types of populations- the vast majority of cells would express unique Tcrbs,
while the repeated Tcrb sequences would reflect a relative abundance of “clonotypes” of 2-3
cells  sharing the same  Tcrb or the presence of very rare larger clone sizes.  However,  the
analysis of the naïve CD8+ T cell population is only compatible with the last hypothesis. It
must  be noted  that  the  majority  of  repeats  found in  the  naïve  CD8+ T cell  pool  express
selected  Tcrbv,  i.e.,  those  that  are  expressed  at  higher  frequency  in  in-frame than  in
out-of-frame  rearrangements,  suggesting  the  same  mechanisms  would  be  involved  in  the
preferential  selection  of  particular  Tcrbv,  and  the  generation  of  relatively  large  clonotype
sizes. 
Thus, the small size clones giving an essentially “private” TCR repertoire unique to each mice
(Turner et al., 2003). However, some “public” T cell response, in which multiple individuals
sharing identical in responding to a same pMHC epitope, giving a much more limited TCRB
diversity,  has  been  observed  in  a  variety  of  immune  responses  (Cibotti  et  al.,  1994;
Kedzierska  et  al.,  2004;  Madi  et  al.,  2014).  Since  these  studies  only  evaluated  TCRB
expression, they may have failed to reveal a more extensive diversity introduced by the TCRA
chain. As shown in a recent study, Tcra expression exposing diversity in an immune response,
reported as having a narrow “public”  Tcrb repertoire (Cukalac et al., 2015).  The  sharing of
TCRB in the naïve T cell repertoire among multiple individuals provides the molecular basis
for public T cell responses  (Cukalac et al.,  2015;  Kedzierska et al., 2006;  La Gruta et al.,
2010). These shared  TCRs may originate  large clones selected to expand due to an optimal
TCR recognition during the immune response.  Several mechanisms have been proposed to
generate  naïve  public  TCRs,  including preferences  in  the  usage frequency and pairing  of
different V-D-J gene segments during initial TCR rearrangement (Turner et al., 2006; Venturi
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et  al.,  2008).  Some  of  these  public  TCR  were  generated  from  a  near-germline  V-D-J
recombination  (Fazilleau  et  al.,  2005;  Venturi  et  al.,  2011)  and  other  by  “convergent
recombination”,  where  individual  cells  expressing  different  Tcrb nucleotide  sequences
“converge” to encode a TCRB protein with the same amino-acid composition (Turner et al.,
2006;  Venturi et al., 2008).  Thymic selection can also influence TCR bias by both limiting
(negative selection) and shaping (positive selection) the public naïve TCR repertoire (Turner
et al., 2006; Venturi et al., 2008). It must be noted that in the 13 mice we studied, we did not
find public Tcrb shared by all mice, and (Quinn et al., 2016) also failed to report such public
sequences in anti-influenza virus repertoires from ten different mice. 
Using this  reliable single-cell approach, our results were striking, and impact in our
holistic  understanding  of  the  immune  system.  During  thymic  differentiation,  pre-T  cells
expressing a TCRB chain undergo 6-8 divisions at the TN3-TN4 transition, and continue to
divide at the immature single-positive (ISP) and at least three times at the DP differentiation
stages  (Kedzierska et al., 2004;  Kreslavsky et al., 2012;  Von Boehmer, 2004).   Because of
TCRB allelic exclusion, thymocytes should maintain the expression of the same TCRB chain
throughout  all  these  divisions,  thus  up  to  211 cells  expressing  the  same  TCRB could  be
generated. Even if only 3% of these cells survived thymic selection events (Huesmann et al.,
1991), one would expect an average clone size of 62 to 102 cells sharing the same TCRB
chain. The difference between this putative average clone size, and the average of 1.1 cells we
here determined can only be explained by the existence of a previously unknown mechanism
determining TCRB repertoires: a selection for virtually complete diversity. 
 It  is  interesting  to  speculate  how  such  extensive  diversity  is  established  and
maintained in the periphery. The remarkable diversity of the peripheral naïve pools indicate
that niches for selection and for optimal cell survival in the thymus or/and in the periphery
must be very diverse and of very reduced size, to allow for cellular competition to impose the
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survival  of  unique  “perfect  fits”.  Peripheral  intra-clonal  and inter-clonal  competition  is  a
component  of  homeostasis  that  contributes  to  selection  and  maintenance  of  a  diverse
peripheral T cell repertoire (Freitas and Rocha, 2000;  Hao et al., 2006;  Hataye et al., 2006;
Leitao et al., 2009). The specificity of TCR contact with a restricting MHC molecule is a
prerequisite for peripheral inter-clonal T cell competition (Agenes et al., 2008). A positive
correlation between the diversity of peptide-MHC complexes expressed in thymic epithelial
cells and the diversity of the T cell repertoire has been demonstrated (Barton and Rudensky,
1999;  SantAngelo  et  al.,  1997).  Moreover,  a  major  selection  process  also  occurs  during
thymus  selection,  where  intra-clonal  competition  and  a  saturable  TCR-specific  dependent
niche for positive selection is also described in the thymus (Bautista et al., 2009; Canelles et
al., 2003). That such selection occurs at the TCR/pMHC interaction can be explained by the
nature of naïve T cells surviving signals, which require TCR/pMHC interactions (Tanchot et
al., 1997).  
Another finding of this study is the remarkable number of CD44high T cells recognizing
the GP33 LCMV peptide in SPF non-infected mice. These “mock memory cells” are known
to  be  generated  by  homeostatic  proliferation  (HP),  although  the  origin  of  the  antigens
inducing their switch from a naïve to a memory phenotype were reported to be diverse and are
likely multiple. We showed that homeostatic proliferation and conversion from the naïve to
the memory CD44high phenotype requires recognition of cross-reactive antigens and that the
degree  of  this  HP  increases  with  the  degree  of  cross-reactivity,  cells  with  multiple
cross-reactivity out-competing slowly proliferating cells (Freitas and Rocha, 2000; Hao et al.,
2006). Such cross-reactivity was attributed to the recognition of self-antigens (Quinn et al.,
2016;  Surh and Sprent, 2000), but stimulation by food antigens and microbiota were also
implicated (Beura et al., 2016; Kim et al., 2016). It was shown that T cells transferred to SCID
germ-free  (GF)  mice  proliferated  slowly,  while  the  same  cells  proliferated  rapidly  when
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transferred to SPF SCID mice (Kieper et al., 2005). These experiments propose a major role
of microbiota and food antigens in inducing rapid HP (Kieper et al., 2005), known to promote
cellular competition (Hao et al., 2006). Moreover, these authors demonstrated the absence of
bacteria in the gut of GF mice at the end of the experiment (Kieper et al., 2005). The major
difficulty  of  maintaining  the  GF  condition  throughout  experiments  and  the  exposure  to
foreign antigens in the form of food (including microbial antigens present in the autoclaved
feed) may explain the different results either supporting a major reduction of CD44high cells in
GF mice (Beura et  al.,  2016;  Dobber  et  al.,  1992;  Kieper  et  al.,  2005) or indicating that
CD44high cells are not modified by the GF condition (Haluszczak et al., 2009;  Quinn et al.,
2016). Cross-reactivity was also demonstrated in human adults, which also have memory cells
that are specific for pathogens that they were not exposed previous (Su et al., 2013).  On the
other hand, all antigen-specific cells in human newborns have a naïve phenotype (Neller et al.,
2015;  Su  et  al.,  2013),  suggesting  a  major  role  of  the  cross-reactivity  to  environmental
antigens  in generation of human  “mock memory cells” (Birnbaum et al.,  2014;  Su et al.,
2013). 
Our study also shows that cross-reactive CD44highGP33+ are particularly abundant in
the BM. The BM is known to have niches that promote the long-term persistence of memory
cells (Geerman et al., 2016). It is possible that these “antigen-experienced” mock memory
cells  have  an  important  role  in  the  response  to  LCMV. Although the  BM is  not  usually
considered as a major a target for the LCMV infection, LCMV can be present directly in BM
(Slifka et al., 1995). Therefore it will be also interesting to evaluate the ability to BM mount
primary immune responses against this virus, thus also functioning as a secondary lymphoid
organ.
The present results also support a theoretical study postulating that the peripheral TCR
repertoires should be extensively cross-reactive. To mobilize enough naïve cells to respond
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efficiently to each individual challenge in primary immune responses, each individual naïve T
cell  should  be  able  to  recognize  multiple  antigens,  and  be  mobilized  in  many  different
responses (Sewell,  2012).  It  remains  to  be  fully  understood  how  the  immune  system
reconciles these three major characteristics: the extensive diversity and cross-reactivity of the
peripheral TCR repertoires with the exquisite specificity of T cell immune responses. 
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Figure legends
Figure 1.  The gating strategy used for the identification and single-cell  sorting of  CD44-
(negative), CD44int (intermediate) and CD44high  TCRαβ+ CD8αβ+  Db-GP33-specific T cells in
lymph nodes, spleen and bone marrow. The detailed methods are described in M&M. Briefly,
a known number of monoclonal CD45.1+ P14 TCR transgenic cells was added to each petri
dish with the different organs from CD45.2+ B6 mice. Cell suspensions from the organs were
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prepared  by  mechanic  disruption  and  collagenase  and  DNAase  digestion,  depleted  of
non-CD8+ T cells and labelled with anti-CD45.1, anti-CD3ε, anti-CD8, anti-CD44, Db GP33
dextramers and Sytox to eliminated dead cells. Cells were successively gated (upper graphs
from left  to  right)  in  CD8+;  CD3+;  Sytox-;  FSC/SSC,  and  doubles  were  eliminated.  The
reference population was identified by CD45.1 expression (middle graphs), and allowed us to
establish the relative loss rate and gates for dextramer Db-GP33+cells (right). These gates were
used to identify, sort or quantify GP33+ cells, in different organs. The numbers shown in each
quadrant represent the mean+/SEM of three mice, each studied in a separate experiment. 
Figure 2.  Relative frequency (%) of TRBV (A); TRBJ usage (B); CDR3 amino-acid length
(C) in CD8+ T cells from SPF B6 mice. Results represent the mean +/- SEM of four mice. The
number  of  Tcrb sequences  studied  in  each mouse  is  shown in  Table  2.  Cells  expressing
TRBV21 are too rare to be visible on this scale.
Figure 3.  Relative frequency (%) of TRBV usage by in-frame (n = 579- grey bars) and
out-of-frame (n = 165-black bars) TCR rearrangements in CD44-CD8+ T cells of SPF B6
mice. Results represent the mean +/- SEM.
Figure 4.   (A) Relative frequency (%) of TRBV usage in the total CD44- (white bars; 3 mice;
386  Tcrb sequences)  versus antigen-specific CD44-GP33+ (black bars,  5 mice;  1.104  Tcrb
sequences) from SPF B6 mice.  (B) Representative dot plots identifying TRBV13 (Vb8) and
TRBV29 (Vb7)  measured  by FACS.  (C)  Relative  frequency  (%)  of  TRBV13 (Vb8)  and
TRBV29 (Vb7) usage in  the total CD44-CD8+ and antigen-specific CD44-GP33+  in spleen
(SP) and bone marrow (BM) from SPF B6 mice.
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